These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18557730)

  • 1. Cytochrome p450 2C enzymes contribute to peritransplant ischemic injury and cardiac allograft vasculopathy.
    Hunter AL; Kerjner A; Mueller KJ; McManus BM; Granville DJ
    Am J Transplant; 2008 Aug; 8(8):1631-8. PubMed ID: 18557730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction.
    Hunter AL; Bai N; Laher I; Granville DJ
    Vascul Pharmacol; 2005 Oct; 43(4):213-9. PubMed ID: 16150654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats.
    Ishihara Y; Sekine M; Nakazawa M; Shimamoto N
    Eur J Pharmacol; 2009 Jun; 611(1-3):64-71. PubMed ID: 19356728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulfaphenazole derivatives on cardiac ischemia-reperfusion injury: association of cytochrome P450 activity and infarct size.
    Ishihara Y; Sekine M; Hamaguchi A; Kobayashi Y; Harayama T; Nakazawa M; Shimamoto N
    J Pharmacol Sci; 2010; 113(4):335-42. PubMed ID: 20644334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.
    Fleming I; Michaelis UR; Bredenkötter D; Fisslthaler B; Dehghani F; Brandes RP; Busse R
    Circ Res; 2001 Jan; 88(1):44-51. PubMed ID: 11139472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
    Moien-Afshari F; Choy JC; McManus BM; Laher I
    J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of vascular heme oxygenase in reduced myogenic reactivity following chronic hypoxia.
    Naik JS; Walker BR
    Microcirculation; 2006 Mar; 13(2):81-8. PubMed ID: 16459321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP epoxygenase-derived H
    Muñoz M; López-Oliva ME; Pinilla E; Martínez MP; Sánchez A; Rodríguez C; García-Sacristán A; Hernández M; Rivera L; Prieto D
    Free Radic Biol Med; 2017 May; 106():168-183. PubMed ID: 28212823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice.
    Elmi S; Sallam NA; Rahman MM; Teng X; Hunter AL; Moien-Afshari F; Khazaei M; Granville DJ; Laher I
    Vascul Pharmacol; 2008 Jan; 48(1):1-8. PubMed ID: 17974492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cadherin expression in cardiac allograft vasculopathy: bench to bedside translational investigation.
    Collot-Teixeira S; McGregor JL; Morser K; Chalabreysse L; McDermott-Roe C; Cerutti C; Guzman A; Michel JB; Boissonnat P; Sebbag L; Thivolet-Bejui F; Bricca G; Obadia JF; Roussoulières A
    J Heart Lung Transplant; 2010 Jul; 29(7):792-9. PubMed ID: 20456977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by sulfaphenazole, a cytochrome p450 inhibitor: mitigation of ischemia-reperfusion injury by scavenging of reactive oxygen species.
    Khan M; Mohan IK; Kutala VK; Kumbala D; Kuppusamy P
    J Pharmacol Exp Ther; 2007 Dec; 323(3):813-21. PubMed ID: 17873104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors.
    Granville DJ; Tashakkor B; Takeuchi C; Gustafsson AB; Huang C; Sayen MR; Wentworth P; Yeager M; Gottlieb RA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1321-6. PubMed ID: 14734800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells.
    Fleming I; Fisslthaler B; Michaelis UR; Kiss L; Popp R; Busse R
    Pflugers Arch; 2001 Jul; 442(4):511-8. PubMed ID: 11510882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
    Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
    Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
    Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
    Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor reduces cardiac allograft vasculopathy.
    Chatur S; Wong BW; Carthy JM; McManus BM
    J Heart Lung Transplant; 2016 Sep; 35(9):1124-30. PubMed ID: 27266812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of beraprost sodium, a stable prostacyclin analogue, on cardiac allograft vasculopathy in rats.
    Kurisu Y; Orihashi K; Sueda T; Kajihara H; Matsuura Y
    Hiroshima J Med Sci; 1997 Mar; 46(1):11-9. PubMed ID: 9114563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ONO-4817, a novel matrix metalloproteinase inhibitor, attenuates allograft vasculopathy in a rat cardiac transplant.
    Hariya A; Takazawa K; Yamamoto T; Amano A
    J Heart Lung Transplant; 2004 Oct; 23(10):1163-9. PubMed ID: 15477110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TNF-alpha-induced reactive oxygen species in endothelial dysfunction during reperfusion injury.
    Gao X; Zhang H; Belmadani S; Wu J; Xu X; Elford H; Potter BJ; Zhang C
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2242-9. PubMed ID: 18849334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.